[ad_1]
ATLANTA – A treatment that helps the immune system fight deadly blood cancers shows promising signs against some solid tumors, giving hope that this approach could be extended to more common cancers in the future.
The treatment, called CAR-T, involves genetically modifying certain cells of the patient in the laboratory to help them recognize and fight cancer.
The first of these CAR-T treatments was released two years ago for some forms of leukemia and lymphoma. Two small studies now suggest that the therapy could be fine-tuned to fight against chest wall or soft tissue and bone cancers.
The results were discussed Sunday at a conference of the American Association for Cancer Research in Atlanta.
Source link
